Shredded 2.0 Injectable (RAD-140 + S4 Andarine + S-23 + YK-11) – Product Information
Shredded 2.0 is a research compound designed to support investigative and research studies. Comprised of a potent blend of RAD-140, S4 Andarine, S-23, and YK-11, Shredded 2.0 offers a unique combination for researchers exploring the potential synergistic effects of these compounds.
RAD-140, S4 Andarine, S-23, and YK-11 are selective androgen receptor modulators (SARMs) that have distinct mechanisms of action and potential synergistic effects when studied together.
When studied together, these compounds may have a synergistic effect on muscle growth, strength gains, and body composition. The combined action of RAD-140, S4 Andarine, S-23, and YK-11 can potentially enhance the anabolic processes, increase protein synthesis, promote muscle hypertrophy, and aid in reducing body fat. Purerawz sells Shredded 2.0 for research purposes only.
- Shredded 2.0 consists of RAD-140, S4 Andarine, S-23, and YK-11.
- Shredded 2.0 is offered as 30mg RAD 140, 30mg S4, 15mg S-23, and 5mg YK-11, totaling 80mg per ml for 10 ml or 800mg in total.
Testolone, also known as RAD 140, as a research compound is being investigated for its potential ability to enhance muscle hypertrophy. Current studies are examining the preclinical characterization of selective androgen receptor modulators and anabolic activity in male cynomolgus monkeys. To assess anabolic activity, one study examined gross body weight, which we know to be a sensitive marker of anabolic androgen action in young nonhuman primates. The results on animal body weight of 28-day dosing with RAD140 were found to be statistically significant. This shows massive promise in the potential muscular gains brought on by Testolone.
|Molar Mass||393.83 g·mol−1|
A scientific study published in 2005 examined the effects of Andarine S-4 in the skeletal muscles, bones, and pituitary glands of castrated male rats. A treatment protocol (3 and 10mg/kg S4- Andarine for 8 weeks) was commenced 12 weeks after castration. Andarine (doses 3 and 10 mg/kg) restored soleus muscle mass and strength and levator ani muscle mass to that seen prior to castration or in intact animals.
This makes S4 an investigational Selective androgen receptor modulator, for possible treatment of conditions related to muscle wasting, osteoporosis, and benign prostatic hyperplasia (BPH). It has the ability to mimic many of the beneficial pharmacologic effects associated with testosterone.
|Molar Mass||128.3 g/mol-1|
According to the available studies, S-23 induced infertility in all rats it was exposed to. These effects are dose-dependent and temporary, meaning the rats regained fertility following treatment. This shows the potential of S-23 as an oral male contraceptive.
According to the research, S-23 subdues serum concentration of luteinizing hormone and follicle-stimulating hormone to produce biphasic effects on spermatogenesis. Additional research and clinical trials should be conducted to determine the efficacy and safety of S-23 as an oral contraceptive.
The above-mentioned study produced other beneficial desirable effects. For instance, researchers observed a stronger affinity to androgen receptors as compared to other popular compounds like Andarine. It also has an ideal anabolic-androgenic ratio allowing it to produce a good number of positive effects without any severe complications. One of those effects was increasing bone mineral density and lean muscle mass.
Therefore, while S-23 may be effective as a male birth control pill, it can also be used for other purposes, especially among patients with chronic conditions that lead to muscle wasting.
|Molar Mass||416.76 g·mol−1|
A recent study has shown that YK11, a selective androgen receptor myostatin inhibitor, accelerates the expression of Follistatin in mice. Follistatin is a myostatin and activin-binding protein naturally found in the human body and has been used as a treatment for several degenerative muscle diseases. When follistatin levels are raised, myostatin levels will be inhibited. Inhibition of myostatin results in increased muscle mass and improved strength.
This study revealed that mice with low levels of myostatin have twice the amount of muscle mass compared to mice with high levels of myostatin. This shows the massive potential research implications of the strong anabolic effects that YK-11 can possess.
|Molar Mass||430.541 g·mol−1|
|IUPAC Name||methyl (2E)-2-[(8R,9S,10R,13S,14S,17S)-2′-methoxy-2′,13-dimethyl-3-oxospiro[1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,5′-1,3-dioxolane]-4′-ylidene]acetate|